Rodino-Klapac Louise 4
4 · Sarepta Therapeutics, Inc. · Filed Nov 19, 2025
Insider Transaction Report
Form 4
Rodino-Klapac Louise
President, R&D and Tech Ops
Transactions
- Tax Payment
Common Stock
2025-11-17$18.42/sh−4,582$84,400→ 224,030 total
Footnotes (1)
- [F1]Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on November 16, 2021.